Application of genomics and biochip technology in research and development of Chinese materia medica

Yaoxue Xuebao

Volumn 37, Issue 6, 2002, Pages 495-496

  Yang, Zhuang ^a   Zhang, Ya Ou ^a   Wong, Maan Sao ^b   Xiao, Pei Gen ^b,c   Yang, Michael M ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

Biochip; Chinese materia medica; Genomics; Research and development

Indexed keywords

CHEMISTRY; DNA MICROARRAY; GENETICS; GENOMICS; HUMAN; MEDICINAL PLANT; PROTEIN MICROARRAY; QUALITY CONTROL; REVIEW;

GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLANTS, MEDICINAL; PROTEIN ARRAY ANALYSIS; QUALITY CONTROL;

EID: 0642307191     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays [J]. Nature, 2000,405(6788):827-836.
2. Harrington CA, Rosenow C, Relief J. Monitoring gene expression using DNA microarrays [J]. Curr Opin Microbiol, 2000,3(3):285-291.
3. Scherf U, Ross DT, Waltham M, et al. A gene expression database for the molecular pharmacology of cancer [J]. Nat Genet, 2000,24(3):236-244.
4. Zweiger G. Knowledge discovery in gene-expression-microarray data: mining the information output of the genome [J]. Trends Biotechnol, 1999,17(11):429-436.
5. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics [J]. Science, 1999,286(5439):487-491.
6. McLeod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy [J]. Annu Rev Pharmacol Toxicol, 2001,41:101-121.
7. Zhu YP. Chinese Materia Medico - Chemistry, Pharmacology and Applications [M]. Harwood: Academic Publishers, 1998.1-32.
8. McCarthy JJ, Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics [J]. Nat Biotechnol, 2000,18(5):505-508.
9. McLeod HL, Krynetski EY, Relling MV, et al. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia [J]. Leukemia, 2000,14(4):567-572.
10. Hoit BD, Suresh DP, Craft L, et al. Beta 2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals [J]. Am Heart J, 2000,139 (3):537-542.
11. Kwok PY, Gu Z. Single nucleotide polymorphism libraries: why and how are we building them? [J] Mol Med Today, 1999,5(12):538-543.
12. Riley JH, Allan CJ, Lai E, et al. The use of single nucleotide polymorphisms in the isolation of common disease genes [J]. Pharmacogenomics, 2000,1(1):39-47.
13. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microairays [J]. Nat Genet, 1999,23(1):41-46.
14. Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development [J]. Trends Pharmacol Sci, 1999,20(5):191 -196.
15. Qin GW, Xu RS. Recent advances on bioactive natural products from Chinese medicinal plants [J]. Med Res Rev, 1998,18(6):375-382.
16. Li SL, Lin G, Chan SW, et al. Determination of the major isosteroidal alkaloids in bulbs of Fritillaria by high-performance liquid chromatography coupled with evaporative light scattering detection [J]. J Chromatogr A, 2001,909 (2):207-214.
17. Shi MM. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies [J]. Clin Chem, 2001,47(2):164-172.
18. Cai ZH, Li P, Dong TTX, et al. Molecular diversity of 5S-rRNA spacer domain in Fritillaria species revealed by PCR analysis [J]. Planta Med, 1999,65(4):360-364.
19. Watanabe CM, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba [J]. Proc Natl Acad Sci USA, 2001,98(12):6577-6580.
20. Li XK, Motwani M, Tong W, et al. Huanglian, A Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells [J]. Mol Pharmacol, 2000,58(6):1287 -1293.
21. Ren M, Ju S, Zhang Z. Curative effect of TCM-WM therapy on Wilson disease with different clinical phenotypes and polymorphisms of ATF7B gene [J]. Chin J Integrated Tradit Chin West Med, 1998,18(11): 652-654.
22. Levenson VV, Davidovich IA, Roninson IB. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response [J]. Cancer Res, 2000,60(18): 5027-5030.
23. Wang J, Huang MH, Tsang LCH, et al. Gene expression profiling in multidrug resistant KB cells using cDNA microarrays [J]. Chin J Cancer Res, 2002,14:11-17.
24. Dirsch VM, Vollmar AM. Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? [J] Biochem Pharmacol, 2001, 61 (5):587-589.
25. Scharfenberg K, Wagner R, Wagner KG. The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines [J]. Cancer Lett, 1990,53(2-3):103-108.
26. Fong CC, Wang MS, Huang M, et al. Gene expression profiling of human promyelocytic leukemia HL-60 cell treated by Ajoene [J]. Chin J Cancer Res, 2002,14:5-10.
27. Dirsch VM, Gerbes AL, Vollmar AM. Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappa B [J]. Mol Pharmacol, 1998,53(3):402-407.
28. Kuzoff RK, Sweere JA, Soltis DE, et al. The phylogenetic potential of entire 26S rDNA sequences in plants [J]. Mol Biol Evol, 1998,15(3):251-263.